SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio

TempraMed to Commence Trading on the Canadian Securities Exchange Under Symbol "VIVI", Today, October 15, 2025

TSX futures rise on Fed rate cut optimism, surging metal prices

The Best Discounted Stocks on the TSX to Snap Up Now

TSX soars on gains in basic materials stocks as U.S.-China trade tensions escalate

Wall Street ends mixed but TSX sharply higher in catch-up rally